Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Biocardia Inc stock

Learn how to easily invest in Biocardia Inc stock.

Biocardia Inc is a biotechnology business based in the US. Biocardia Inc shares (BCDA) are listed on the NASDAQ and all prices are listed in US Dollars. Biocardia Inc employs 28 staff and has a trailing 12-month revenue of around $1.9 million.

How to buy shares in Biocardia Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BCDA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Biocardia Inc stock price (NASDAQ: BCDA)

Use our graph to track the performance of BCDA stocks over time.

Biocardia Inc shares at a glance

Information last updated 2022-09-25.
Latest market close$1.94
52-week range$1.10 - $3.49
50-day moving average $1.73
200-day moving average $1.78
Wall St. target price$8.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.76

Buy Biocardia Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biocardia Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biocardia Inc price performance over time

Historical closes compared with the close of $1.94 from 2022-09-30

1 week (2022-09-23) 4.30%
1 month (2022-09-02) 2.11%
3 months (2022-07-01) 32.88%
6 months (2022-03-29) N/A
1 year (2021-10-01) -35.12%
2 years (2020-10-02) -16.02%
3 years (2019-10-02) 3.55
5 years (2017-09-29) 317.20%

Biocardia Inc financials

Revenue TTM $1.9 million
Gross profit TTM $-7,543,000
Return on assets TTM -47.61%
Return on equity TTM -107.01%
Profit margin 0%
Book value $0.38
Market capitalisation $33 million

TTM: trailing 12 months

Biocardia Inc share dividends

We're not expecting Biocardia Inc to pay a dividend over the next 12 months.

Have Biocardia Inc's shares ever split?

Biocardia Inc's shares were split on a 1:9 basis on 6 June 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biocardia Inc shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Biocardia Inc shares which in turn could have impacted Biocardia Inc's share price.

Biocardia Inc share price volatility

Over the last 12 months, Biocardia Inc's shares have ranged in value from as little as $1.1 up to $3.49. A popular way to gauge a stock's volatility is its "beta".

BCDA.US volatility(beta: 1.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biocardia Inc's is 1.2273. This would suggest that Biocardia Inc's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Biocardia Inc overview

BioCardia, Inc. , a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California. .

Frequently asked questions

What percentage of Biocardia Inc is owned by insiders or institutions?
Currently 30.703% of Biocardia Inc shares are held by insiders and 17.256% by institutions.
How many people work for Biocardia Inc?
Latest data suggests 28 work at Biocardia Inc.
When does the fiscal year end for Biocardia Inc?
Biocardia Inc's fiscal year ends in December.
Where is Biocardia Inc based?
Biocardia Inc's address is: 320 Soquel Way, Sunnyvale, CA, United States, 94085
What is Biocardia Inc's ISIN number?
Biocardia Inc's international securities identification number is: US09060U5074
What is Biocardia Inc's CUSIP number?
Biocardia Inc's Committee on Uniform Securities Identification Procedures number is: 09060U101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site